Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Oct 12:2024.05.02.591343.
doi: 10.1101/2024.05.02.591343.

TRMT1L-catalyzed m2 2G27 on tyrosine tRNA is required for efficient mRNA translation and cell survival under oxidative stress

Affiliations

TRMT1L-catalyzed m2 2G27 on tyrosine tRNA is required for efficient mRNA translation and cell survival under oxidative stress

Sseu-Pei Hwang et al. bioRxiv. .

Update in

Abstract

tRNA modifications are critical for several aspects of their functions, including decoding, folding, and stability. Using a multifaceted approach encompassing eCLIP-seq and Nanopore tRNA-seq, we show that the human tRNA methyltransferase TRMT1L interacts with component of the Rix1 ribosome biogenesis complex and binds to the 28S rRNA, as well as to a subset of tRNAs. Mechanistically, we demonstrate that TRMT1L is responsible for catalyzing m2 2G solely at position 27 of tRNA-Tyr-GUA. Surprisingly, TRMT1L depletion also impaired the deposition of acp3U and dihydrouridine on tRNA-Tyr-GUA, Cys-GCA, and Ala-CGC. TRMT1L knockout cells have a marked decrease in tRNA-Tyr-GUA levels, coinciding with a reduction in global translation rates and hypersensitivity to oxidative stress. Our results establish TRMT1L as the elusive methyltransferase catalyzing the m2 2G27 modification on tRNA Tyr, resolving a long-standing gap of knowledge and highlighting its potential role in a tRNA modification circuit crucial for translation regulation and stress response.

Keywords: N2, N2-dimethylguanosine (m22G); Nanopore tRNA-seq; RNA methyltransferases; TRMT1L; eCLIP-seq; oxidative stress response; rRNA; tRNA; translation.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTERESTS The authors declare no competing interests.

Figures

Figure 1.
Figure 1.
TRMT1L interacts with components of the Rix1 60S biogenesis complex in nucleolus. (A) Mass spectrometry analysis of PELP1-associated complexes. (B) Western blot analysis of endogenous PELP1 or (C) TRMT1L immunoprecipitated (IP). Asterisk indicates the presence of the IgG cross-reactivity band. (D) Schematic representation of TRMT1L and TRMT1 proteins. (E) Immunofluorescence detection of endogenous TRMT1L. (F) Inhibition of rRNA transcription by CX-5461 impairs TRMT1L nucleolar localization in U2OS cells. See also Figure S1.
Figure 2.
Figure 2.
TRMT1L co-sediments with pre-60S ribosomes. (A) Pre-ribosomal particles from sucrose gradient fractionation. Proteins and RNA from each fraction were analyzed by Western blot (top panel) or by Northern blot (bottom panel), respectively. (B) RNAi depletion of TRMT1L was confirmed by immunoblotting and densitometry quantification Data are presented as mean ± SD. N=3 (C) Nuclear pre-ribosomes from TRMT1L depleted cells were separated by sucrose gradient fractionation and analyzed by Western blot. See also Figure S2.
Figure 3.
Figure 3.
TRMT1L binds to tRNAs and rRNA. (A) eCLIP-sequencing analysis showing percentage of reads in SMInputs and TRMT1L IP samples mapped to CLIP peak regions for HCT116 cells. (B) Log2 fold enrichment of TRMT1L IP over SMInput with adjusted p values < 0.05, fold change ≥ 2, and basemean ≥ 1000 from HCT116 or (C) HeLa duplicates for different tRNA iso-decoders. See also Figure S3 and S4 and Table S1.
Figure 4.
Figure 4.
Nano-tRNAseq identifies potential tRNA modification changes in TRMT1L-depleted cells. (A) Heatmap of summed base calling errors in TRMT1L KO cells vs. WT, for each nucleotide and tRNA. Triangles mark positions with significantly decreased errors. (B) Snapshots of IGV tracks for tRNA alignments. (C) The percentage of deletions and mismatches at each position of tRNA iso-decoders were extracted and summarized from the .mpileup file. * p < 0.05. Data are presented as mean ± SD. N=2. See also Figure S5 and S6 and Table S2.
Figure 5.
Figure 5.
TRMT1L catalyzes the deposition of m22G27 on tRNA-Tyr. (A) Primer extension analysis of tRNAs in WT, TRMT1L KO cells and in TRMT1L KO cells re-expressing TRMT1L WT or TRMT1L D373V mutant. (B) Extracted ion chromatograms of tRNA-Tyr-GUA RNase A digestion products. (D) Extracted ion chromatograms of tRNA-Cys-GCA RNase T1 digestion products. (E) Sypro Ruby protein gel stain and Western blot analysis of purified Flag-TRMT1L WT and TRMT1L D373V. (F-G) In vitro transcribed tRNAs were incubated with purified Flag-TRMT1L WT or D373V from (E) and analyzed by immune-Northern blotting with m22G antibody and densitometry quantification of the m22G signals. Data are presented as mean ± SD. N=3. (H) The modifications on in vitro transcribed tRNA-Tyr WT, G26A and G27A after incubating with Flag-TRMT1L WT were analyzed by primer extension assay. Irrelevant lanes have been cropped. See also Figure S5 and S6.
Figure 6.
Figure 6.
TRMT1L-depleted cells show a reduced abundance in tRNA-Tyr. (A) Nano-tRNAseq scatter plots of tRNA abundances of WT and (B) TRMT1L KO cells across biological replicates. The correlation strength is indicated by the Pearson correlation coefficient (r). (C) Volcano plot showing differential expression of tRNAs in TRMT1L KO relative to WT. The threshold of differential expression was set as p < 0.05 and absolute log2 fold change > 0.6. (D, G, J) Diagram showing the probes designed to cover different regions of tRNA-Tyr and tRNA-Cys. (E) Total RNAs from HCT116 WT and TRMT1L KO cells were analyzed by Northern blot using the indicated Tyr-GUA and U6 probes. (F) Densitometry quantification of Tyr-GUA signal normalized to U6 probe signal from (E) Data are presented as mean ± SD. N=3. (H-I, K-L) Total RNAs from HCT116 WT and TRMT1L KO cells were analyzed by Northern blot using the depicted tRNA-Tyr probes, tRNA-Cys probes and U6 probe. Approximate sizes of fragments detected in nucleotides are indicated on the side of each panel. Diagram showing the speculative fragments generated from a cut at position 26/27. The blots in (K-L) were done on the same membrane. See also Figure S7.
Figure 7.
Figure 7.
TRMT1L-depleted cells exhibit reduced global translation rate and increased sensitivity to oxidative and ER stresses. (A) WT and TRMT1L KO HCT116 cells were analyzed by polysome profiling. (B) HCT116 cells were transfected with siRNAs and treated with puromycin for the indicated time and analyzed by Western blot with the indicated antibodies. (C) WT and TRMT1L KO HCT116 cells were monitored for proliferation by cell counting. Relative cell counts were normalized to the cell counts on day 1. ns: p > 0.05. (D) WT and TRMT1L KO HCT116 cells were subjected to different stress conditions and live cells were counted after 48 h of treatment. Data are presented as mean ± SD. N=3.

References

    1. Gilbert W.V., and Nachtergaele S. (2023). mRNA Regulation by RNA Modifications. Annu Rev Biochem 92, 175–198. 10.1146/annurev-biochem-052521-035949. - DOI - PMC - PubMed
    1. Wiener D., and Schwartz S. (2021). The epitranscriptome beyond m(6)A. Nat Rev Genet 22, 119–131. 10.1038/s41576-020-00295-8. - DOI - PubMed
    1. Suzuki T. (2021). The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol 22, 375–392. 10.1038/s41580-021-00342-0. - DOI - PubMed
    1. Kirchner S., and Ignatova Z. (2015). Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat Rev Genet 16, 98–112. 10.1038/nrg3861. - DOI - PubMed
    1. Ohira T., and Suzuki T. (2024). Transfer RNA modifications and cellular thermotolerance. Mol Cell 84, 94–106. 10.1016/j.molcel.2023.11.041. - DOI - PubMed

Publication types